Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#3947 Heterogeneity of multiple pancreatic neuroendocrine tumors identified by 68Ga-DOTANOC and 68Ga-exendin-4 PET/CT in a patient with endogenous hyperinsulinemic hypoglycaemia and multiple endocrine neoplasia 1

Introduction: Insulinomas are the most frequent functional neuroendocrine tumors of pancreas cause endogenous hyperinsulinemic hypoglycemia (EHH). In about 10% cases, insulinomas are associated with multiple endocrine neoplasia 1 (MEN1).

Conference:

Presenting Author: Xu J

Authors: Xu X, Xu X, Liang Y, Zhang M, Chen J,

Keywords: MEN1, insulinoma, 68Ga-DOTANOC, 68Ga-exendin-4, PET/CT,

#3824 A rare clinical case of giant pituitary ACTH adenoma

Introduction: Cushing's disease is a neuroendocrine disease that is associated with ACTH-secreting pituitary microadenomas whereas macro- and giant adenomas are less common.

Conference:

Presenting Author:

Authors: Lastovkina A, Ilovaiskaya I, Komerdus I, Motrenko A, Zakharova P,

Keywords: Cushing's disease, giant corticotropinoma, hypercortisolism,

#3782 Somatostatin analogues (SSA) in gastroenteropancreatic neuroendocrine tumors (GEP-NET) – Impact on glycemia and lipid profile in a monocentric series

Introduction: Somatostatin analogues (SSA) are often the first line therapy in neuroendocrine tumors (NET). The management of hyperglycaemia and dyslipidaemia are one of the most important challenges in healthcare. The impact of SSA on metabolic profile in GEP-NET is highly debated.

Conference:

Presenting Author: Cannavale G

Authors: Cannavale G, Benevento E, Minotta R, Liccardi A, Modica R,

Keywords: SSA, lipid profile, glycemia, GEP-NET, hyperglycaemia, Somatostatin analogues,

#3767 Metabolic alterations in patients with pheochromocytoma/paragangliomas and SDHB mutations

Introduction: Pheochromocytoma/paragangliomas (PPGL) patients with SDHB mutation may have unfavourable course of disease. SDHB gene inactivation results in up-regulation of glycolytic reaction and activation of pseudo-hypoxic phenotype in preclinical studies.

Conference:

Presenting Author: Benevento E

Authors: Benevento E, Cannavale G, Liccardi A, Minotta R, Modica R,

Keywords: pheochromocytoma, paraganglioma, SDHB,

#3324 Elastographic localization of insulinoma

Introduction: A 15-year-old healthy female, initially admitted with less serious signs of hypoglycemia. Laboratory studies showed a glucose concentration of 1.2 mmol/l and insulin 9.6 μU/ml. Complete blood count, basal metabolic profile, activity of C - reactive protein and urine drug screen, were unremarkable. Fasting test confirmed biochemical signs of insulinoma.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Uhrík P

Authors: Uhrík P, Nosakova L, Pindura M, Bánovčin P, Hyrdel R,

Keywords: insulinoma, endosonography, elastography,